Intrinsic Value of S&P & Nasdaq Contact Us

Cencora, Inc. COR NYSE

NYSE • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
53/100
2/7 Pass
SharesGrow Intrinsic Value
$386.89
+20.9%
Analyst Price Target
$408.00
+27.5%

Cencora, Inc. (COR) — Analyst outlook / Analyst consensus target is. Based on 46 analyst ratings, the consensus is bullish — 33 Buy, 12 Hold, 1 Sell.

The consensus price target is $408.00 (low: $340.00, high: $440.00), representing an upside of 27.5% from the current price $319.90.

Analysts estimate Earnings Per Share (EPS) of $13.65 and revenue of $292.54B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $7.60 vs est $13.65 (missed -44.3%). 2025: actual $8.02 vs est $15.94 (missed -49.7%). Analyst accuracy: 11%.

COR Stock — 12-Month Price Forecast

$408.00
▲ +27.54% Upside
Average Price Target
Based on 46 Wall Street analysts offering 12-month price targets for Cencora, Inc., the average price target is $408.00, with a high forecast of $440.00, and a low forecast of $340.00.
The average price target represents a +27.54% change from the last price of $319.90.
Highest Price Target
$440.00
Average Price Target
$408.00
Lowest Price Target
$340.00

COR Analyst Ratings

Buy
46
Ratings
33 Buy
12 Hold
1 Sell
Based on 46 analysts giving stock ratings to Cencora, Inc. in the past 3 months
Rating breakdown
Buy
33 72%
Hold
12 26%
Sell
1 2%
72%
Buy
33 analysts
26%
Hold
12 analysts
2%
Sell
1 analysts

EPS Estimates — COR

11%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $7.60 vs Est $13.65 ▼ 79.6% off
2025 Actual $8.02 vs Est $15.94 ▼ 98.7% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.

Revenue Estimates — COR

100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $293.959B vs Est $292.539B ▲ 0.5% off
2025 Actual $321.333B vs Est $321.049B ▲ 0.1% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message